Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 48 (2014): Issue 2 (June 2014)
Open Access
Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab
Robert Königsberg
Robert Königsberg
,
Julia Maierhofer
Julia Maierhofer
,
Tanja Steininger
Tanja Steininger
,
Gabriele Kienzer
Gabriele Kienzer
and
Christian Dittrich
Christian Dittrich
| Apr 25, 2014
Radiology and Oncology
Volume 48 (2014): Issue 2 (June 2014)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Apr 25, 2014
Page range:
184 - 188
Received:
Aug 27, 2013
Accepted:
Nov 18, 2013
DOI:
https://doi.org/10.2478/raon-2013-0083
Keywords
breast cancer
,
Her2/neu
,
trastuzumab
,
bevacizumab
,
VEGF
© by Robert Königsberg
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.